X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs STRIDES SHASUN LTD - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD STRIDES SHASUN LTD ALEMBIC LTD/
STRIDES SHASUN LTD
 
P/E (TTM) x 74.8 14.0 535.7% View Chart
P/BV x 2.8 1.9 147.1% View Chart
Dividend Yield % 0.4 0.6 73.2%  

Financials

 ALEMBIC LTD   STRIDES SHASUN LTD
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
STRIDES SHASUN LTD
Mar-16
ALEMBIC LTD/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs531,413 3.7%   
Low Rs29848 3.5%   
Sales per share (Unadj.) Rs4.7353.3 1.3%  
Earnings per share (Unadj.) Rs8.823.4 37.5%  
Cash flow per share (Unadj.) Rs9.041.0 22.0%  
Dividends per share (Unadj.) Rs0.155.00 3.0%  
Dividend yield (eoy) %0.40.4 82.6%  
Book value per share (Unadj.) Rs27.7320.4 8.7%  
Shares outstanding (eoy) m267.0389.35 298.9%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x8.73.2 271.8%   
Avg P/E ratio x4.748.3 9.7%  
P/CF ratio (eoy) x4.627.6 16.5%  
Price / Book Value ratio x1.53.5 42.0%  
Dividend payout %1.721.4 8.0%   
Avg Mkt Cap Rs m10,962100,988 10.9%   
No. of employees `000NA4.7 0.0%   
Total wages/salary Rs m2384,988 4.8%   
Avg. sales/employee Rs ThNM6,730.0-  
Avg. wages/employee Rs ThNM1,063.6-  
Avg. net profit/employee Rs ThNM445.5-  
INCOME DATA
Net Sales Rs m1,26031,564 4.0%  
Other income Rs m2641,212 21.8%   
Total revenues Rs m1,52432,776 4.7%   
Gross profit Rs m835,213 1.6%  
Depreciation Rs m611,573 3.9%   
Interest Rs m01,803 0.0%   
Profit before tax Rs m2853,049 9.3%   
Minority Interest Rs m0127 0.0%   
Prior Period Items Rs m2,096-27 -7,792.6%   
Extraordinary Inc (Exp) Rs m-32-371 8.7%   
Tax Rs m6689 0.9%   
Profit after tax Rs m2,3432,089 112.1%  
Gross profit margin %6.616.5 39.8%  
Effective tax rate %2.122.6 9.5%   
Net profit margin %185.96.6 2,808.2%  
BALANCE SHEET DATA
Current assets Rs m1,68935,949 4.7%   
Current liabilities Rs m48619,402 2.5%   
Net working cap to sales %95.452.4 182.0%  
Current ratio x3.51.9 187.5%  
Inventory Days Days21771 305.9%  
Debtors Days Days81127 63.9%  
Net fixed assets Rs m1,62434,478 4.7%   
Share capital Rs m534894 59.8%   
"Free" reserves Rs m5,96022,601 26.4%   
Net worth Rs m7,40428,632 25.9%   
Long term debt Rs m10427,455 0.4%   
Total assets Rs m8,01076,591 10.5%  
Interest coverage x950.72.7 35,326.5%   
Debt to equity ratio x01.0 1.5%  
Sales to assets ratio x0.20.4 38.2%   
Return on assets %29.35.1 575.6%  
Return on equity %31.67.3 433.6%  
Return on capital %31.38.2 383.1%  
Exports to sales %2.948.1 6.1%   
Imports to sales %28.914.5 199.5%   
Exports (fob) Rs m3715,192 0.2%   
Imports (cif) Rs m3644,565 8.0%   
Fx inflow Rs m3716,612 0.2%   
Fx outflow Rs m3655,292 6.9%   
Net fx Rs m-32811,320 -2.9%   
CASH FLOW
From Operations Rs m346717 48.2%  
From Investments Rs m-48-22,284 0.2%  
From Financial Activity Rs m-30129,488 -1.0%  
Net Cashflow Rs m-38,073 -0.0%  

Share Holding

Indian Promoters % 64.0 27.7 231.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 37.8 0.5%  
FIIs % 9.7 8.6 112.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 25.9 100.8%  
Shareholders   54,701 56,241 97.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   IPCA LABS  NOVARTIS  ALEMBIC PHARMA  MERCK LTD  SANOFI INDIA  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 18, 2017 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - PLETHICO PHARMA COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS